Aethon Therapeutics
New York, US · Founded 2022
Biotech
Founders & leadership
WE
William EngelsExecutive Officer
SH
Seth HarrisonDirector
PD
Paul Da Silva JardineExecutive Officer, Director
RC
Rajesh ChopraExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements▶$6MraisedDec 2022 · 2 investors · BiotechnologyRule 506(b)
▶$6MraisedDec 2022 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William EngelsExecutive Officer
- Seth HarrisonDirector
- Paul Da Silva JardineExecutive Officer, Director
- Rajesh ChopraExecutive Officer, Director
- Offering amount
- $30M
- Amount sold
- $6M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.